$245.80
5.82% day before yesterday
NYSE, Apr 11, 10:10 pm CET
ISIN
US0905721082
Symbol
BIO
Sector

Bio-Rad Laboratories, Inc. Class B Stock price

$245.80
-5.21 2.08% 1M
-91.12 27.05% 6M
-82.71 25.18% YTD
-66.07 21.19% 1Y
-343.91 58.32% 3Y
-159.58 39.37% 5Y
+107.86 78.19% 10Y
NYSE, Closing price Fri, Apr 11 2025
+13.51 5.82%
ISIN
US0905721082
Symbol
BIO
Sector

Key metrics

Market capitalization $6.89b
Enterprise Value $6.59b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 22.82
EV/Sales (TTM) EV/Sales 2.57
P/S ratio (TTM) P/S ratio 2.68
P/B ratio (TTM) P/B ratio 1.05
Revenue growth (TTM) Revenue growth -3.92%
Revenue (TTM) Revenue $2.57b
EBIT (operating result TTM) EBIT $331.47m
Free Cash Flow (TTM) Free Cash Flow $289.00m
Cash position $1.67b
EPS (TTM) EPS $-65.04
P/S forward 2.70
EV/Sales forward 2.58
Short interest 4.96%
Show more

Is Bio-Rad Laboratories, Inc. Class B a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Bio-Rad Laboratories, Inc. Class B Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Bio-Rad Laboratories, Inc. Class B forecast:

6x Buy
67%
3x Hold
33%

Analyst Opinions

9 Analysts have issued a Bio-Rad Laboratories, Inc. Class B forecast:

Buy
67%
Hold
33%

Financial data from Bio-Rad Laboratories, Inc. Class B

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2,567 2,567
4% 4%
100%
- Direct Costs 1,173 1,173
5% 5%
46%
1,393 1,393
3% 3%
54%
- Selling and Administrative Expenses 617 617
0% 0%
24%
- Research and Development Expense 252 252
12% 12%
10%
524 524
11% 11%
20%
- Depreciation and Amortization 193 193
6% 6%
8%
EBIT (Operating Income) EBIT 331 331
14% 14%
13%
Net Profit -1,844 -1,844
189% 189%
-72%

In millions USD.

Don't miss a Thing! We will send you all news about Bio-Rad Laboratories, Inc. Class B directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bio-Rad Laboratories, Inc. Class B Stock News

Neutral
MCAP MediaWire
20 days ago
IRVINE, Calif., March 24, 2025 – PRISM MediaWire – Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, today published the following letter to shareholders in conjunction with its fourth quarter results: Fellow Shareholders, Our dynamic team is making swift progress toward delivering a regulated organ transplant rejection monitoring test kit to the market next year.
Neutral
Seeking Alpha
about 2 months ago
Bio-Rad Laboratories, Inc. (NYSE:BIO ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants Edward Chung - Vice President of Investor Relations Jon DiVincenzo - President & Chief Operating Officer Roop Lakkaraju - Executive Vice President & Chief Financial Officer Norman Schwartz - Chairman of the Board, President & Chief Executive Officer Conference Call Participa...
Neutral
Business Wire
about 2 months ago
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the fourth quarter and full year ended December 31, 2024. Norman Schwartz, Bio-Rad's Chairman and Chief Executive Officer, commented: “Bio-Rad demonstrated resilience and adaptability in 2024. While...
More Bio-Rad Laboratories, Inc. Class B News

Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Head office United States
CEO Norman Schwartz
Employees 7,700
Founded 1952
Website www.bio-rad.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today